Moderna says dual variant booster with Beta more effective vs Omicron than current shot

Moderna Inc on Tuesday said a COVID-19 booster designed to target the Beta variant as well as the original coronavirus generated a better immune response against a number of virus variants including Omicron.

Moderna said the results were a good sign for the company's plans for future shots targeting two COVID-19 variants.